Page last updated: 2024-11-04

dichlorvos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dichlorvos: An organophosphorus insecticide that inhibits ACETYLCHOLINESTERASE. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dichlorvos : An alkenyl phosphate that is the 2,2-dichloroethenyl ester of dimethyl phosphate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3039
CHEMBL ID167911
CHEBI ID34690
SCHEMBL ID25067
MeSH IDM0006282

Synonyms (297)

Synonym
dichlorvos (ddvp)
BIDD:ER0583
dimethyl 2,2-dichlorovinyl phosphate
o,o-dimethyl dichlorovinyl phosphate
dimethyl dichlorovinyl phosphate
atgard c
tap 9vp
OKO ,
unifos (pesticide)
nci-c00113
dimethyl 2,2-dichloroethenyl phosphate
lindanmafu
2,2-dichlorovinyl dimethyl phosphate
krecalvin
o-(2,o-dimethylphosphat
algard
nsc6738
vapona insecticide
task
szklarniak
vinylophos
dedevap
herkol
bay-19149
nsc-6738
phosphoric acid,2-dichloroethenyl dimethyl ester
equigel
fekama
xlp 30
atgard v
brevinyl
0,2-dichlorovinyl phosphate
phosvit
ddvp
fecama
(2,2-dichloro-vinil)dimetil-fosfato
wln: gygu1opo&o1&o1
vinylofos
sd-1750
phosphoric acid 2,2-dichlorovinyl dimethyl ester
dichlorman
vinyl alcohol,2-dichloro-, dimethyl phosphate
dichlorfos
ent-20738
canogard
nerkol
dichlorovos
nuvan
dichloorvo
bibesol
(2,2-dichloor-vinyl)-dimethyl-fosfaat
divipan
oms 14
(2,2-dichlor-vinyl)-dimethyl-phosphat
dichlorophos
2,2-dichloroethenyl dimethyl phosphate
equigard
ethenol,2-dichloro-, dimethyl phosphate
marvex
brevinyl e-50
dichlorphos
vaponite
sd 1750
herkal
nogos
62-73-7
chlorvinphos
unifos
ddvf
o,2-dichlor-vinyl)-phosphat
dichlorvos
mopari
nogos g
phosphoric acid,2-dichlorovinyl dimethyl ester
nuvan 100 ec
dimethyl o,2-phosphate
winylophos
nogos 50
vapona
tenac
estrosel
phosphate, 2-2-dichlorovinyl dimethyl
ddvp (insecticide)
dichlorovas
dimethyldichlorovinyl phosphate
brevinyl e 50
atgard
cekusan
phosphate de dimethyle et de 2,2-dichlorovinyle
KBIO1_001400
DIVK1C_006456
duravos
dimethyl-2,2-dichlorovinyl phosphate
CHEBI:34690 ,
D03791
dichlorvos (usan/inn)
atgard (tn)
SPECTRUM_001779
unitox
phosphoric acid 2,2 dichloroethenyl dimethyl ester
o-(2, 2-dichlorvinyl)-o,o-dimethylphosphat
dichlorfos(polish)
(2, 2-dichlor-vinyl)-dimethyl-phosphat
(2, 2-dichloro-vinil)dimetil-fosfato
dimethyl o, o-dichlorovinyl-2,2-phosphate
ethenol, 2, 2-dichloro-, dimethyl phosphate
o,o-dimethyl-o-(2, 2-dichlor-vinyl)-phosphat
0, 0-dimethyl 0-2,2-dichlorovinyl phosphate
phosphoric acid, 2,2-dichloroethenyl dimethyl ester
vinyl alcohol, 2,2-dichloro-, dimethyl phosphate
(2,2-dichloor-vinyl)-dimethyl-fosfaat (dutch)
phosphoric acid, 2,2-dichlorovinyl dimethyl ester
BSPBIO_002279
SPECTRUM5_001930
NCGC00090997-01
NCGC00090997-02
dichlorvos (vapona)
cypona
udvf
dichlorfos [polish]
estrosol
2,2-dichloroethenyl phosphoric acid dimethyl ester
hsdb 319
delevap
verdisol
o,o-dimethyl-o-(2,2-dichlor-vinyl)-phosphat [german]
fly-die
nogos 50 ec
diclorvos
des (phosphate)
novotox
insectigas d
verdipor
astrobot
2,2-dichlorovinyl dimethyl phosphoric acid ester
nuvan 7
phosphoric acid 2,2-dichloroethenyl dimethyl ester
ccris 230
dichlorvosum [inn-latin]
epa pesticide chemical code 084001
ai3-20738
apavap
panaplate
diclorvos [inn-spanish]
nuva
o,o-dwumetylo-o-dwuchlorowinylofosforan [polish]
dichloorvo [dutch]
nefrafos
ent 20738
derriban
brn 1709141
denkavepon
(2,2-dichloor-vinyl)-dimethyl-fosfaat [dutch]
deriban
tetravos
nsc 6738
bayer 19149
vapora ii
mafu strip
equigand
benfos
o,o-dimethyl o-2,2-dichlorovinyl phosphate
(2,2-dichloro-vinil)dimetil-fosfato [italian]
devikol
no-pest strip
no-pest
brevinyl e50
bay-b 4986
phosphate de dimethyle et de 2,2-dichlorovinyle [french]
unifos 50 ec
dichlorvos [bsi:iso]
einecs 200-547-7
o,o-dimethyl 2,2-dichlorovinyl phosphate
nuvan 100ec
dichlofos
task tabs
2,2-dichlorovinyl alcohol dimethyl phosphate
(2,2-dichlor-vinyl)-dimethyl-phosphat [german]
fly fighter
ethenol, 2,2-dichloro-, dimethyl phosphate
dichlorvos [usan:inn:ban]
caswell no. 328
2,2-dichlorovinyl-o,o-dimethyl phosphate
mafu
verdican
uniphos
dichloroethenyl dimethyl phosphate
2,2-dichloroethenol dimethyl phosphate
derribante
equiguard
o-(2,2-dichlorvinyl)-o,o-dimethylphosphat [german]
NCGC00090997-04
NCGC00090997-03
KBIO3_001779
KBIOGR_000999
KBIOSS_002260
KBIO2_004827
KBIO2_007395
KBIO2_002259
SPBIO_001074
SPECTRUM2_001227
SPECTRUM3_000810
SPECPLUS_000360
SPECTRUM4_000650
NCGC00090997-05
NCGC00090997-06
dimethyl 2,2-dichlorovinylphosphate
HMS2091C21
oebrkcosufcwjd-uhfffaoysa-
inchi=1/c4h7cl2o4p/c1-8-11(7,9-2)10-3-4(5)6/h3h,1-2h3
smr000777927
MLS002222471
AKOS005111045
CHEMBL167911 ,
bdbm50286926
A833962
2,2-bis(chloranyl)ethenyl dimethyl phosphate
NCGC00090997-09
NCGC00090997-08
NCGC00090997-07
2,2-dichlorovinyl
tox21_300840
NCGC00259166-01
NCGC00254743-01
tox21_201617
tox21_111052
dtxcid90449
dtxsid5020449 ,
cas-62-73-7
CCG-39147
o,o-dwumetylo-o-dwuchlorowinylofosforan
dichlorvosum
o-(2,2-dichlorvinyl)-o,o-dimethylphosphat
o,o-dimethyl-o-(2,2-dichlor-vinyl)-phosphat
unii-7u370bps14
7u370bps14 ,
dichlorvos [mi]
dichlorvos [green book]
dichlorvos [inn]
dichlorvos [iso]
dichlorvos [iarc]
dichlorvos [usp-rs]
dichlorvos [mart.]
dichlorvos [hsdb]
dichlorvos [who-dd]
dichlorvos [usan]
SCHEMBL25067
tox21_111052_1
NCGC00090997-11
o-(2,2-dichlorvinyl)-o,o-dimethylphosphate
OEBRKCOSUFCWJD-UHFFFAOYSA-N
2,2-dimethyldichlorovinyl phosphate
prima u
(2,2-dichlorovinyl)-dimethyl-fosfate
dichlorovinphos
o-o-dimethyl-o(2,2-dichlorovinyl)phosphate
nuvos
AB00053012_02
mfcd00036123
SR-05000001548-1
sr-05000001548
dichlorvos, pestanal(r), analytical standard
dichlorvos, united states pharmacopeia (usp) reference standard
aquaguard
o-(2,2-dichloroethenyl) o,o-dimethyl phosphate, 9ci
dimethyl o,o-dichlorovinyl-2,2-phosphate
2,2-dichlorovinyl dimethyl phosphate, 8ci
phosphoric acid, 2-dichloroethenyl dimethyl ester
SBI-0052506.P003
Q420622
DB11397
dichlorvos 100 microg/ml in acetonitrile
dichlorvos 1000 microg/ml in acetone
dichlorvos 100 microg/ml in n-hexane
vapona ii
atgard swine wormer, atgard v swine wormer
dichlorvos (iarc)
nuvan 500 ec
unifos 50ec
sd1750
atgard swine wormer 27 g, atgard swine wormer 5.4g, atgard v swine wormer 27 g, atgard v swine wormer 5.4 g
nogos 500
brevinyl weedat 0002
atgard c premix 9.6%
celcusan
task dog anthelmintic
diclorvos (inn-spanish)
o,o-dimethyl-o-2,2-dichlorvinyl dimethyl phosphate
dichlorvos (usp-rs)
atgard c swine wormer
o,o-dimethyl-o-(2,2-dichlorovinyl)phosphate
dichlorvosum (inn-latin)
dichlorvos (mart.)
equigard, verdisol
(2,2-dichloor-vinyl)-dimethyl-phosphat
usepa/opp pesticide code: 084001
phosvit 75

Research Excerpts

Overview

Dichlorvos (DDVP) is an organophosphorous insecticide which is classified as "highly hazardous" Class 1B chemical by World Health Organization (WHO) largely misused for the purpose of self-poisoning in developing countries. DichlorVos is a known risk factor for organ toxicity.

ExcerptReferenceRelevance
"Dichlorvos is a widely used organophosphorus fumigant that is ubiquitous in the environment."( Effects of short-term exposure to volatile pesticide dichlorvos on the olfactory systems in Spodoptera litura: Calcium homeostasis, synaptic plasticity and apoptosis.
Chen, J; Fang, SM; Li, SS; Yu, QY; Zhang, Z, 2023
)
1.88
"Dichlorvos (DDVP) is an organophosphorous insecticide which is classified as "highly hazardous" Class 1B chemical by World Health Organization (WHO) and largely misused for the purpose of self-poisoning in developing countries. "( Simple determination of dichlorvos in cases of fatal intoxication by gas Chromatography-Mass spectrometry.
A S Abourehab, M; Chauhan, V; Deswal, B; Jain, B; Jain, R; Kaur, S; Sharma, S, 2023
)
2.66
"Dichlorvos is a common crop insecticide widely used by people which causes extensive and serious environmental pollution. "( Investigation of the effects of dichlorvos poisoning on AMPK signaling pathway in chicken brain tissues.
Cao, H; Guo, X; Hu, G; Latigo, V; Li, G; Li, L; Liu, P; Wu, C; Xiao, Y; Xu, Z; Zheng, X; Zhou, C, 2020
)
2.28
"Dichlorvos is a known risk factor for organ toxicity. "( Suppression of uric acid generation and blockade of glutathione dysregulation by L-arginine ameliorates dichlorvos-induced oxidative hepatorenal damage in rats.
Abidoye, AO; Adekunle, AO; Akhigbe, RE; Dare, OS; Saka, WA, 2021
)
2.28
"Dichlorvos (DDVP) is an organophosphorus compound with insecticidal effects. "( Dichlorvos poisoning caused chicken cerebrum tissue damage and related apoptosis-related gene changes.
Gu, Y; Guo, X; Hu, G; Huang, C; Li, G; Liu, P; Wu, C; Xu, Z, 2021
)
3.51
"Dichlorvos (DDVP) is an insecticide with neurotoxicity that is widely used in agricultural production and life. "( Correlation between acute brain injury and brain metabonomics in dichlorvos-poisoned broilers.
Cao, H; Cheng, S; Guo, X; Hu, G; Huang, C; Huang, L; Li, G; Liu, P; Liu, X; Wu, C; Xu, Z; Zhang, C; Zhao, Y; Zhou, C; Zhuang, Y, 2022
)
2.4
"Dichlorvos is an important insecticide used largely. "( Acute dichlorvos poisoning induces hemorheological abnormalities in rabbits via oxidative stress.
He, D; Jia, B; Ka, W; Sun, D; Wang, X; Wen, Z; Yao, W; Zhang, X, 2010
)
2.28
"Dichlorvos is a synthetic insecticide and belongs to a family of chemically related organophosphate pesticides (OP)."( Cellular and molecular mechanisms of dichlorvos neurotoxicity: cholinergic, nonchlolinergic, cell signaling, gene expression and therapeutic aspects.
Binukumar, BK; Gill, KD, 2010
)
1.35
"Dichlorvos is an organophosphorus insecticide that is used worldwide for pest control in agriculture and household use. "( Dichlorvos-induced testicular toxicity in male rats and the protective role of vitamins C and E.
Dirican, EK; Kalender, Y, 2012
)
3.26
"Dichlorvos (DIC) is an organophosphate compound with cholinergic and noncholinergic neurotoxicity as well as non-neuronal cytotoxicity. "( microRNA and mRNA expression profiling analysis of dichlorvos cytotoxicity in porcine kidney epithelial PK15 cells.
Li, S; Ran, XQ; Wang, JF; Xu, L, 2011
)
2.06
"Dichlorvos is a synthetic insecticide that belongs to the family of chemically related organophosphate (OP) pesticides. "( Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain.
Bal, A; Gill, KD; Gudup, S; Kandimalla, RJ; Sharma, DR; Singh, PP; Sunkaria, A; Wani, WY, 2011
)
2.04
"Dichlorvos (DDVP) is an organophosphate compound that causes neurotoxicity. "( Caspase 1, caspase 3, TNF-alpha, p53, and Hif1-alpha gene expression status of the brain tissues and hippocampal neuron loss in short-term dichlorvos exposed rats.
Acar, K; Boz, B; Dodurga, Y; Kurtulus, A; Nilufer Yonguc, G, 2012
)
2.02
"Dichlorvos is an acutely toxic organophosphorous pesticide that is known as a classical acetylcholinesterase (AChE; EC 3.1.1.7) inhibitor. "( Effect of dichlorvos on the acetylcholinesterase from tambaqui (Colossoma macropomum) brain.
Amaral, IP; Assis, CR; Bezerra, RS; Carvalho, LB; Castro, PF, 2007
)
2.18
"Dichlorvos (DDVP) is a methylating agent. "( Alkylating properties of dichlorvos (DDVP).
Ehrenberg, L; Segerbäck, D, 1981
)
2.01
"Dichlorvos (DDVP) is an organophosphate insecticide used to protect museum specimens from insect pests. "( Respiratory exposure of museum personnel to dichlorvos insecticide.
Beck, ED; Deer, HM; Roe, AH, 1993
)
1.99
"Dichlorvos, which is a phosphoric ester with a dichlorovinyl group as side chain, and trichlorphon, which is known for its spontaneous conversion in dichlorvos, are both mutagenic in Salmonella (strain TAI535) and Streptomyces."( Mutagenicity of dichlorvos and other structurally related pesticides in Salmonella and Streptomyces.
Cardamone, G; Carere, A; Morpurgo, G; Ortali, VA, 1978
)
1.33

Effects

Dichlorvos has been in widespread use as an insecticide for over 40 years. Its carcinogenicity and genotoxicity have been evaluated extensively.

ExcerptReferenceRelevance
"dichlorvos has been investigated in relation to selected water hardness for the freshwater zooplankters such as Moina, Daphnia, cyclops and nauplii."( Acute toxicity of organophosphate insecticide, dichlorvos in relation to selected water hardness for the freshwater zooplankters.
Gupta, AK; Jain, KL; Verma, GP, 2008
)
1.32
"Dichlorvos (DDVP) has been studied in 11 cancer bioassays. "( Dichlorvos--a comprehensive review of 11 rodent carcinogenicity studies.
Ishmael, J; MacGregor, JA; Manley, A, 2006
)
3.22
"Dichlorvos has been in widespread use as an insecticide for over 40 years, during which time its carcinogenicity and genotoxicity have been evaluated extensively. "( Review of the in vitro and in vivo genotoxicity of dichlorvos.
Booth, ED; Elliott, BM; Jones, E, 2007
)
2.03

Actions

Dichlorvos did not cause cholinomimetic symptoms even though blood cholinesterase was significantly inhibited (plasma -51.3% and erythrocyte -43.7%).

ExcerptReferenceRelevance
"Dichlorvos poisoning can cause muscarinic (M) -like symptoms, nicotinoid (N) -like symptoms and central nervous system manifestations. "( [Application of extracorporeal membrane oxygenation technique in patients with refractory shock caused by dichlorvos poisoning].
Liu, QY; Sun, JJ; Wang, TT, 2023
)
2.57
"Dichlorvos did not cause cholinomimetic symptoms even though blood cholinesterase was significantly inhibited (plasma -51.3% and erythrocyte -43.7%)."( Latent dichlorvos neurotoxicity detected by vagal tone monitoring in dogs.
Dellinger, JA; Koritz, GD; McKiernan, BC; Richardson, BC,
)
1.31

Treatment

Dichlorvos treatment caused marked inhibition in cAMP synthesis as indicated by decreased adenylate cyclase activity as well as cAMP levels in cerebrum, cerebellum and brain stem. In dichlorvas-treated quail embryos, the ultrastructural cytochemistry of gonads reveals perturbations in the glycoconjugate distribution.

ExcerptReferenceRelevance
"Dichlorvos treatment caused marked inhibition in cAMP synthesis as indicated by decreased adenylate cyclase activity as well as cAMP levels in cerebrum, cerebellum and brain stem."( Altered cholinergic metabolism and muscarinic receptor linked second messenger pathways after chronic exposure to dichlorvos in rat brain.
Gill, KD; Raheja, G, 2007
)
1.27
"In dichlorvos-treated quail embryos, the ultrastructural cytochemistry of gonads reveals perturbations in the glycoconjugate distribution. "( [Ultrastructure and cytochemistry of primordial germ cells involved in migration in dichlorvos-treated quail embryos].
Bruel, MT; David, D, 1981
)
1.11
"Dichlorvos treatment of aflatoxigenic Aspergillus parasiticus SYS-4 (NRRL 2999) or a verscolorin A-accumulating mutant, NIAH-9, resulted in accumulation of versiconol acetate (VOAc) and versiconal hemiacetal acetate (VHA), whereas the production of aflatoxins, versicolorin A (VA), and versiconol (VOH) decreased. "( A metabolic grid among versiconal hemiacetal acetate, versiconol acetate, versiconol and versiconal during aflatoxin biosynthesis.
Ando, Y; Hamasaki, T; Yabe, K, 1991
)
1.72
"The treatment of dichlorvos poisoning practically eliminate stressogenic effects of dichlorvos."( Treatment of the stressogenic effect of dichlorvos.
Bajgar, J; Kassa, J, 1994
)
0.88
"Treatment with dichlorvos may have precipitated these events."( Caval syndrome in a Dirofilaria immitis-infected dog treated with dichlorvos.
Eaton, KA; Rosol, TJ, 1989
)
0.85

Toxicity

Naled was more acutely toxic than permethrin and dichlorvos to caterpillars. Toxic effects could be mediated through modifications in the intracellular calcium homeostasis which may lead to impaired neuronal function.

ExcerptReferenceRelevance
" Preincubation of erythrocytes with glutathione prevented the toxic effects of the pesticide with the maintenance of both glutathione and methemoglobin at a control level."( Erythro-toxicity of dichlorvos and possibility of its modification in vitro.
Grabarczyk, M; Woźniak, J, 1992
)
0.61
" These compounds produced toxic effects on hepatocytes as evidenced by malondialdehyde production and lactate dehydrogenase leakage in a dose-dependent manner up to the concentration of 2 mM, dichlorvos being more toxic than trichlorfon."( Hepatotoxicity of trichlorfon and dichlorvos in isolated rat hepatocytes.
Morita, S; Yamano, T, 1992
)
0.75
" These results indicate that the enzymes SOD and catalase may enhance the disposal of potentially toxic radicals."( Neurotoxicity of dichlorvos: effect on antioxidant defense system in the rat central nervous system.
Gill, KD; Julka, D; Pal, R, 1992
)
0.62
" Using the same protocol, six pesticides applied in dimethyl sulfoxide (DMSO) at doses of 1/8, 1/16, and 1/32 of the dermal LD50 were investigated."( Comparison of the activity of topically applied pesticides and the herbicide 2,4-D in two short-term in vivo assays of genotoxicity in the mouse.
Goldberg, MT; Hardy, MH; Schop, RN, 1990
)
0.28
" The approximate LD50 values calculated by this method showed little difference between two separate laboratories and were in good agreement with LD50 values reported in the literature."( A simple method for screening assessment of acute toxicity of chemicals.
Hashimoto, M; Kobayashi, K; Nishimura, M; Sekizawa, J; Tobe, M; Yamanaka, S, 1990
)
0.28
" musculus to the toxic effects of DDVP, both species were exposed to 0, 3 and 6 g of pelleted DDVP per cage."( Dichlorvos toxicity in the white-footed mouse (Peromyscus leucopus).
Brodie, SJ; DiGiacomo, RF; Giddens, WE; Van Hoosier, GL, 1987
)
1.72
" The PTZ alone was not toxic and did not inhibit EACE activity."( Toxicity and interaction of topical organophosphate insecticide dichlorvoscrotoxyphos and phenothiazine anthelmintic in sheep previously exposed to both drugs.
Mohammad, FK; St Omer, VV, 1985
)
0.51
" The cumulative LD50 dose depended upon the time interval between injections of toxic agent."( Factors modifying the toxicity of organophosphorus compounds including dichlorvos.
Sterri, SH, 1981
)
0.5
" In hens double doses of trichlorphon each exceeding unprotected LD50 can produce moderate neuropathy associated with appropriately high inhibitions of neurotoxic esterase."( Delayed neurotoxicity - do trichlorphon and/or dichlorvos cause delayed neuropathy in man or in test animals?
Johnson, MK, 1981
)
0.52
" To evaluate the potential toxicity of prophylactic anti- parasitic treatments on strains of mice that are commonly used as experimental models and in genetic engineering in our facility, we surveyed a number of strains and ages of mice for toxic reactions during treatment regimens that combine anthelminthic and anti-acaricidal agents."( Toxicity evaluation of prophylactic treatments for mites and pinworms in mice.
Frazier, S; Oberbeck, C; Rehg, JE; Straign, CM; Toth, LA, 2000
)
0.31
" The results presented herein, indicate that the toxic effects of dichlorvos could be mediated through modifications in the intracellular calcium homeostasis which may lead to impaired neuronal function."( Calcium homeostasis and dichlorvos induced neurotoxicity in rat brain.
Gill, KD; Raheja, G, 2002
)
0.86
" Organophosphorus insecticide, dichlorvos (DDVP), was employed as a model chemical for assessing conventional ozonation and catalytic ozonation, because its oxidative intermediate is toxic and is not degraded by direct ozonation."( Catalytic ozonation of an organophosphorus pesticide using microporous silicate and its effect on total toxicity reduction.
Fujita, H; Kim, BS; Sakai, Y; Sakoda, A; Suzuki, M, 2002
)
0.6
" In summary, the 50% dichlorvos containing insecide formulation (Unifosz 50 EC) and the 50% atrazine containing herbicide formulation (Hungazin PK 50 WP) were toxic to the developing chicken embryos at the highest concentration in our study."( Toxicity of a dichlorvos containing insecticide formulation and an atrazine containing herbicide formulation in chicken embryos after individual administration.
Budai, P; Fejes, S; Juhász, E; Keseru, M; Pongrácz, A; Szabó, R, 2004
)
1
"The indiscriminate use of pesticides and herbicides to increase crop productivity has aroused a great concern among the environmental and health scientists due to their adverse effects in both target as well as non-target species."( In vitro induction of cytotoxicity and DNA strand breaks in CHO cells exposed to cypermethrin, pendimethalin and dichlorvos.
Bajpayee, M; Dhawan, A; Pandey, AK; Parmar, D; Patel, S, 2007
)
0.55
"The study highlights the adverse effects of organophosphate compounds dichlorvos and chlorpyrifos on reproduction in Drosophila."( Adverse effect of organophosphate compounds, dichlorvos and chlorpyrifos in the reproductive tissues of transgenic Drosophila melanogaster: 70kDa heat shock protein as a marker of cellular damage.
Chowdhuri, DK; Gupta, SC; Mathur, N; Mishra, RK; Mitra, K; Saxena, DK; Siddique, HR, 2007
)
0.83
"This study evaluates the toxic effects of the organophosphate pesticide (OP) dichlorvos to the endangered Iberian toothcarp (Aphanius iberus)."( Acute toxicity of dichlorvos to Aphanius iberus (Cuvier & Valenciennes, 1846) and its anti-cholinesterase effects on this species.
Amat, F; Navarro, JC; Varó, I, 2008
)
0.91
"Acute toxic effects of three commonly used insecticidal preparations of the organophosphates chlorpyrifos, diazinon, and dichlorvos were examined in mixed breed broiler chicks, and cholinesterase activity in plasma and brain were measured."( Acute toxicity and cholinesterase inhibition in chicks dosed orally with organophosphate insecticides.
Al-Badrany, YM; Al-Jobory, MM; Mohammad, FK, 2008
)
0.55
" Results revealed that dichlorvos was highly toxic to the tested zooplankters, as the LC50 values are noticed in ppb."( Acute toxicity of organophosphate insecticide, dichlorvos in relation to selected water hardness for the freshwater zooplankters.
Gupta, AK; Jain, KL; Verma, GP, 2008
)
0.91
" A simplified central composite design (SCCD) was employed to design the concentration distribution of components in binary mixtures to effectively detect the possible toxic interactions between pesticide and IL over the whole concentration range."( Effect of ionic liquid on the toxicity of pesticide to Vibrio-qinghaiensis sp.-Q67.
Liu, HL; Liu, SS; Zhang, J, 2009
)
0.35
"Inappropriate use of toxic chemicals is common in developing countries, where it leads to excessive exposure and high risks of unintentional poisoning."( Cellular and molecular mechanisms of dichlorvos neurotoxicity: cholinergic, nonchlolinergic, cell signaling, gene expression and therapeutic aspects.
Binukumar, BK; Gill, KD, 2010
)
0.63
" Based on LD50s, thorax and wing application exposures were acutely toxic to both caterpillars and adults."( Use of butterflies as nontarget insect test species and the acute toxicity and hazard of mosquito control insecticides.
Frakes, RA; Hoang, TC; Pryor, RL; Rand, GM, 2011
)
0.37
" The significant increase in mRNA levels of the corresponding genes may be considered as a defence mechanism in addition to the antioxidants against oxidative stress, as well as a detoxification mechanism against adverse effects of pesticides."( Chronic toxicity of pesticides to the mRNA expression levels of metallothioneins and cytochrome P450 1A genes in rainbow trout.
Aksakal, E; Atabeyoglu, K; Ceyhun, SB; Erdogan, O; Kirim, B, 2012
)
0.38
" Therefore, an analysis of the metabolic profiles can contribute to the understanding of the adverse effects of long-term exposure to low doses of DDVP."( Metabolomic analysis of the toxic effects of chronic exposure to low-level dichlorvos on rats using ultra-performance liquid chromatography-mass spectrometry.
Feng, Z; Hao, D; Sun, C; Sun, X; Wang, M; Yang, J; Zhao, X, 2011
)
0.6
" The sperm counts and sperm motility decreased significantly as the toxic concentration arised."( [Synergistic effect of dichlorvos, dimethoate and malathion mixture on reproduction toxicity in male mice].
Hu, SK; Yan, H; Yang, AM; Yu, Y; Zhang, JH, 2011
)
0.68
"Formulation components of organophosphate insecticidal preparations might affect their toxic action in animals."( Acute toxicity of veterinary and agricultural formulations of organophosphates dichlorvos and diazinon in chicks.
Al-Zubaidy, MH; Hasan, MM; Mohammad, FK; Mousa, YJ, 2011
)
0.6
" However, they were five orders of magnitude less toxic than either chlorpyrifos or dichlorvos."( Toxicity of Zanthoxylum piperitum and Zanthoxylum armatum oil constituents and related compounds to Stomoxys calcitrans (Diptera: Muscidae).
Ahn, YJ; Hieu, TT; Kim, SI, 2012
)
0.6
" These results suggested that DDVP residues might become toxic chemical contaminant in environment and would threaten aquatic and other organisms."( Toxicity effect of dichlorvos on loach (Misgurnus anguillicaudatus) assessed by micronucleus test, hepatase activity analysis and comet assay.
Chang, Z; Chen, J; Du, Q; Li, L; Nan, P; Yan, S, 2015
)
0.75
" A comparison of the MERA with the conventional isobologram and the extended toxic unit summation revealed that the MERA characterizes the degree of toxicity interaction in the view of effect, with less limitation by different concentration ratios or effect levels."( [Characterizing the toxicity interaction of the binary mixture between DMSO and pesticide by the multi-effect residual analysis (MERA)].
Huo, XC; Liu, SS; Zhang, J, 2013
)
0.39
" These toxic effects were also regulated by high-dose quercetin."( Effect of quercetin against dichlorvos induced nephrotoxicity in rats.
Hou, Y; Li, S; Qi, L; Sun, C; Wang, H; Xu, W; Zeng, Y; Zhao, X, 2014
)
0.7
" These pesticides are highly toxic to humans and their residues in food pose potential threat to human health."( Combined subchronic toxicity of dichlorvos with malathion or pirimicarb in mice liver and serum: a metabonomic study.
Li, L; Li, W; Liang, YJ; Sun, YJ; Wang, HP; Wang, P; Wu, YJ; Xu, MY; Yang, L, 2014
)
0.69
"0055 mg cm(-3) ) was the most toxic fumigant and was 15."( Fumigant toxicity of basil oil compounds and related compounds to Thrips palmi and Orius strigicollis.
Ahn, YJ; Kim, JR; Kim, KH; Kim, SI; Lee, SG; Yi, CG, 2015
)
0.42
" Based on 24-h LD50s for ingestion, naled was more acutely toxic than permethrin and dichlorvos to caterpillars."( Acute toxicity and risk assessment of permethrin, naled, and dichlorvos to larval butterflies via ingestion of contaminated foliage.
Hoang, TC; Rand, GM, 2015
)
0.88
"Because of the widespread use of dichlorvos (DDVP) for domestic applications, evaluation of their toxic effects is of major concern to public health."( Lycopene attenuates dichlorvos-induced oxidative damage and hepatotoxicity in rats.
El-Gaaly, GA; El-Saad, AA; Hazani, AA; Ibrahim, MM, 2016
)
1.04
"016 mg cm(-3) ) were the most toxic fumigant compounds and were 10."( Toxicity of Lavandula angustifolia oil constituents and spray formulations to insecticide-susceptible and pyrethroid-resistant Plutella xylostella and its endoparasitoid Cotesia glomerata.
Ahn, YJ; Choi, BR; Hieu, TT; Kwon, M; Lee, SH; Yi, CG, 2016
)
0.43
"This study raises awareness to the use of toxic pesticides and reiterates the well-known danger of these pesticides."( Acute Toxicity of the Pesticides, Dichlorvos and Lindane against the African air-breathing catfish, Heterobranchus longifilis, Valenciennes, 1840 (Siluriformes: Clariidae).
Ikeogu, GC; Oribhabor, BJ, 2016
)
0.71
"The test pesticides were found to be differentially toxic to the test species."( Acute Toxicity of the Pesticides, Dichlorvos and Lindane against the African air-breathing catfish, Heterobranchus longifilis, Valenciennes, 1840 (Siluriformes: Clariidae).
Ikeogu, GC; Oribhabor, BJ, 2016
)
0.71
" The result demonstrated that more toxic products may be produced during the biodegradation processes of OPs, and more attention should be put not only on the pesticides themselves, but also on the toxic effects of their degradation products."( Microbial degradation of organophosphorus pesticides: novel degraders, kinetics, functional genes, and genotoxicity assessment.
Chen, Y; Jiang, B; Li, G; Lian, L; Song, Y; Sun, G; Xing, Y; Zhang, D; Zhang, N, 2019
)
0.51

Pharmacokinetics

ExcerptReferenceRelevance
" Metrifonate was quickly absorbed with a Cmax of 50."( Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood.
Abdi, YA; Villén, T, 1991
)
0.52
" A significant difference in the pharmacokinetic parameters of O (except for T(max) and t(1/2,lambdaz)) was found when the plasma samples were treated with dichlorvos."( Studies on the influence of esterase inhibitor to the pharmacokinetic profiles of oseltamivir and oseltamivir carboxylate in rats using an improved LC/MS/MS method.
Chang, Q; Chow, MS; Zuo, Z, 2009
)
0.55
" However, pharmacokinetic data have not been obtained."( Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey.
Bird, SB; Carville, A; Jackson, CJ; Mansfield, K; Ollis, DL; Scott, C, 2010
)
0.36

Compound-Compound Interactions

In this study, two prediction models were developed using visible/near-infrared (Vis/NIR) spectroscopy combined with partial least squares discriminant analysis. The models were used for the detection of pesticide residues of avermectin, dichlorvos, and chlorothalonil at different concentration levels on the surface of cauliflowers.

ExcerptReferenceRelevance
" It is suggested that bispiridinium oximes combined with M-cholinolytics can play a corrective role in eliminating the adverse presynaptic effect of a cholinolytic, thus lowering the severity of intoxication."( [The mechanisms of the antidotal action of bispyridinium oximes when used in combination with M-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Dolgo-Saburov, VB; Filipppov, VN; Kosmachev, AB; Podosinovikova, NP,
)
0.13
"Using 1-butyl-3-methylimidazolium hexafluorophosphate ([BMIM][PF6]) room temperature ionic liquid (RTIL) as extraction solvent, tetrahydrofuran (THF) as disperser solvent, the organophosphorus pesticide dichlorvos in water was determined by dispersive liquid-liquid microextraction (DLLME) combined with high-performance liquid chromatography."( Trace determination of dichlorvos in environmental samples by room temperature ionic liquid-based dispersive liquid-phase microextraction combined with HPLC.
Tang, Q; Wang, S; Xiang, B, 2012
)
0.88
"In this study, two prediction models were developed using visible/near-infrared (Vis/NIR) spectroscopy combined with partial least squares discriminant analysis (PLS-DA) and least squares support vector machine (LS-SVM) for the detection of pesticide residues of avermectin, dichlorvos, and chlorothalonil at different concentration levels on the surface of cauliflowers."( Non-destructive detection and recognition of pesticide residue levels on cauliflowers using visible/near-infrared spectroscopy combined with chemometrics.
Li, Y; Li, Z; Liu, Y; Wang, K; Xue, J; Yin, J; Zhang, M, 2023
)
1.09

Bioavailability

ExcerptReferenceRelevance
"5 mg/kg of body weight to ponies and horses, and was highly bioavailable (F = 41."( Pharmacokinetics of bacampicillin in equids.
McKellar, QA; Sarasola, P, 1995
)
0.29
" The optimal extraction ratio, considering the electrochemical interferences and the effect on enzyme activity and bioavailability of the pesticide, was 1:10."( An electrochemical bioassay for dichlorvos analysis in durum wheat samples.
Compagnone, D; De Gregorio, M; Del Carlo, M; Fournier, D; Marty, JL; Mascini, M; Pepe, A; Visconti, A, 2006
)
0.62
" Although CoQ10 is an efficient antioxidant, its poor bioavailability has limited the applications of this useful agent."( Protective effects of coenzyme Q10 nanoparticles on dichlorvos-induced hepatotoxicity and mitochondrial/lysosomal injury.
Ahmadian, E; Azami, A; Eftekhari, A; Eghbal, MA; Johari-Ahar, M, 2018
)
0.73
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

The reproductive toxicity of the pesticides dicofol, dichlorvos, permethrin, endosulfan, and dieldrin was evaluated in rats. Administration to rats, dosed with Nippostrongylus brasiliensis, of pyrantel and/or fenbendazole was more successful in killing adult worms than administration of the pure drug alone.

ExcerptRelevanceReference
" Ronnel did not have an effect on ChE activity, whereas dichlorvos and cythioate, at all dosage levels, had an inhibitory effect."( Motor unit irritability in Beagles Before and after exposure to cholinesterase inhibitors.
Bowen, JM; Hazelwood, JC; Stefan, GE, 1979
)
0.51
"A single dose of dichlorvos (2,2-dichlorovinyl dimethyl phosphate) was administered orally at a dosage of 30 mg/kg to 19 dogs naturally infected with Trichuris vulpis and to 13 dogs experimentally infected with T vulpis."( Efficacy of dichlorvos administered orally in single and repeated doses for removal of canine whipworms.
Gundlach, CE; Olsen, JL; Rollins, LD; Rosenberg, MC, 1977
)
0.98
" The drug is shown to display a marked antidotal action when used in a dosage range of 490-10 mg/kg."( [Experimental data on a new cholinesterase reactivator from the group of thiohydroximic esters].
Kagan, IuS; Kokshareva, NV; Krivenchuk, VE; Sasinovich, LM,
)
0.13
"1's have been determined for the 5 organophosphates from an unbalanced design, loaded heavily toward the lower end of the dose-response curve."( Estimation of the LD1 and extrapolation of the LD0.1 for five organophosphate pesticides.
Dooley, KL; Farmer, JH; Haley, TJ; Harmon, JR, 1975
)
0.25
" Acute tetrahydroaminoacridine (THA) dosing caused lower brain (68%) and higher plasma (90%) ChE inhibition than the other drugs studied and increased levels of brain dihydroxyphenylacetic acid (DOPAC) (236%), homovanillic acid (HVA) (197%) and 5-hydroxyindoleacetic acid (5-HIAA) (130%)."( Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
Shillcutt, S; Soininen, H; Unni, L, 1990
)
0.28
" An increase in blood glucose and total plasma proteins occurred during the dosing period; these parameters returned to control values in surviving animals within 7 d after the final dose."( The influence of repeated oral administration of dichlorvos on circulating esterases in buffalo calves (Bubalus bubalis).
Malik, JK; Raina, R; Srivastava, AK, 1990
)
0.53
"The induction of central-peripheral distal axonopathy in hens singly dosed with some organophosphorus (OP) compounds, such as di-n-butyl-2,2-dichlorovinyl phosphate (DBDCVP), requires greater than 80% organophosphorylation and subsequent intramolecular rearrangement ("aging") of a protein [neuropathy target esterase (NTE)] in the axon."( Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy.
Lotti, M; Moretto, A; Sabri, MI; Spencer, PS, 1987
)
0.49
" Although liver SD is significantly elevated in the single and repeated dosage study, serum SD appears unaffected at these levels of dichlorvos toxicity."( Serum and liver enzyme changes in rats after short term exposure to dichlorvos.
Campbell, PI; Ofurum, OO, 1986
)
0.71
"05) in the group of the higher dosed animals when compared with the group of the vehicle control male rats."( [Studies on dichlorvos (DDVP). II. Testing of dichlorvos for carcinogenic activity in rats].
Horn, KH; Nischan, P; Schramm, T; Teichmann, B, 1988
)
0.65
" musculus at any dosage level."( Dichlorvos toxicity in the white-footed mouse (Peromyscus leucopus).
Brodie, SJ; DiGiacomo, RF; Giddens, WE; Van Hoosier, GL, 1987
)
1.72
" Dichlorvos also inhibited CaCl2 dose-response curves in K+-depolarized strips, as well as depressing both phasic and tonic components of NE-induced contractions."( Inhibitory effect of dichlorvos on arterial smooth muscle contraction.
Campbell, PI; Ebeigbe, AB, 1986
)
1.5
" No dependence on dosage was demonstrated."( [The effect of dichlorvos and metathion on selected enzymes of the amoeba Tetrahymena pyriformis].
Hrusovský, J; Mojzis, J; Nistiar, F, 1985
)
0.62
" In the DDVP-treated quail (10 min after dosage of 3 mg/kg), free acetylcholine (ACh), labile-bound ACh, increased significantly and acetylcholinesterase (AChE) decreased to 28% of the value determined in untreated quail."( Effects of organophosphorus compounds, O,O-dimethyl O-(2,2-dichlorovinyl)phosphate (DDVP) and O,O-dimethyl O-(3-methyl 4-nitrophenyl)phosphorothioate (fenitrothion), on brain acetylcholine content and acetylcholinesterase activity in Japanese quail.
Kobayashi, H; Kudo, M; Matsusaka, N; Yuyama, A, 1983
)
0.27
" Suppression occurred after a dosage which produced cholinergic effects but was absent after a lower dosage which did not produce cholinergic signs."( The effects of organophosphate-induced cholinergic stimulation on the antibody response to sheep erythrocytes in inbred mice.
Casale, GP; Cohen, SD; DiCapua, RA, 1983
)
0.27
" Treatment of 4 the dosage rate of 44 mg/kg was consistently effective (greater than 99% to 100%) for eliminating intestinal infections of S westeri."( Controlled tests of pastes of dichlorvos and thiabendazole against induced Strongyloides westeri infections in pony foals in 1973-1974.
Drudge, JH; Lyons, ET; Tolliver, SC, 1982
)
0.55
" The toxic effects were numerically scored in a random blind fashion and the concentrations of individual chemicals to produce a half maximal effect (IC50) in culture were determined from the dose-response curves."( Cytotoxic responses of selected insecticides in chick ganglia cultures.
Obersteiner, EJ; Sharma, RP, 1981
)
0.26
" 1 day after dosing inhibition of neurotoxic esterase in peripheral nerve was 79-90%, in spinal cord 70-81% and in brain 89-92%."( Delayed neurotoxicity caused by a single massive dose of dichlorvos to adult hens.
Caroldi, S; Lotti, M, 1981
)
0.51
" Oral administration of dichlorvos (60 mg/kg, 3 times the anthelmintic dosage level) 1 hour before levamisole injection lowered blood cholinesterase activity to approximately 60% that of the controls, but did not change the LD50 of levamisole."( Drug interactions of levamisole with pyrantel tartrate and dichlorvos in pigs.
Hsu, WH, 1981
)
0.81
" Both compounds reach peak levels in blood within two hours after oral dosing and are detectable for at least eight hours."( Levels of metrifonate and dichlorvos in plasma and erythrocytes during treatment of schistosomiasis with Bilarcil.
Bengtsson, E; Holmstedt, B; Nordgren, I; Pettersson, BM, 1981
)
0.56
"Transdermal delivery of cholinesterase inhibitors (ChEI) for treatment of dementia would have advantages associated with continuous dosing and enhanced compliance, but feasibility depends on achieving desired levels of central nervous system enzyme inhibition."( Transdermal patch delivery of acetylcholinesterase inhibitors.
Becker, RE; Moriearty, PL; Thornton, SL,
)
0.13
"97 mg kg-1 DDVP, respectively, throughout gestation (GD1-birth) and during suckling via oral dosing to the dams, and then via the same doses by gavage for the rest of their lives."( Life-time exposure to dichlorvos affects behaviour of mature rats.
Dési, I; Nagymajtényi, L; Schulz, H, 1995
)
0.61
" 15 min before dichlorvos dosing significantly reduced the development of toxicity and increased 24-h survival rates to 87 and 100% respectively."( Prevention and treatment of dichlorvos-induced toxicosis in mice by diphenhydramine.
Faris, GA; Mohammad, FK, 1997
)
0.94
" However, following multiple dosing a statistically significant 3-fold increase in mutant frequency was observed in the liver, while a non-statistically significant increase was observed in the bone marrow."( Induction of somatic mutations but not methylated DNA adducts in lambdalacZ transgenic mice by dichlorvos.
Baan, RA; Kyrtopoulos, SA; Pletsa, V; Steenwinkel, MJ; van Delft, JH, 1999
)
0.52
" White Leghorn hens were dosed with the neuropathic compounds di-1-butyl-2,2-dichlorovinyl phosphate (dibutyl dichlorvos, DBDCV), tri-o-cresyl phosphate (TOCP), or acrylamide, and regions from brain were fractionated into axolemmal, synaptosomal, and microsomal preparations."( Brainstem axolemmal protein phosphorylation in vitro in hens dosed with di-1-butyl-2,2-dichlorovinyl phosphate.
Huggins, DJ; Richardson, RJ, 1999
)
0.52
" Administration to rats, dosed with Nippostrongylus brasiliensis, of pyrantel and/or fenbendazole and pigs, dosed with Ascaris and Oesophagostomum, of dichlorvos (DDVP) loaded onto zeolite Y was more successful in killing adult worms than administration of the pure drug alone."( The use of zeolites as slow release anthelmintic carriers.
Dyer, A; Morgan, S; Wells, P; Williams, C, 2000
)
0.51
" Air concentrations of dichlorvos in the mud hut were shown to be definitely lower than those in a plywood hut at the same dosage level."( DICHLORVOS AS A RESIDUAL FUMIGANT IN MUD, PLYWOOD AND BAMBOO HUTS.
MATHIS, W; PEARCE, GW; SCHOOF, HF, 1963
)
1.99
" Even the maximum dosage rate tested (one dispenser per 60 cubic feet (1."( INITIAL FIELD STUDIES IN UPPER VOLTA WITH DICHLORVOS RESIDUAL FUMIGANT AS A MALARIA ERADICATION TECHNIQUE. 3. TOXICOLOGICAL EVALUATION.
FUNCKES, AJ; HAYES, WJ; MILLER, S, 1963
)
0.51
" The objective of the trial was to see if dichlorvos would interrupt the transmission of malaria under local conditions when used at a dosage of one dispenser per 15 m(3) of living space."( A LARGE-SCALE FIELD TRIAL WITH DICHLORVOS AS A RESIDUAL FUMIGANT INSECTICIDE IN NORTHERN NIGERIA.
FOLL, CV; LIETAERT, PE; PANT, CP, 1965
)
0.79
" We therefore propose a reconsideration of the individual effective dose or individual tolerance concept postulated by Gaddum 50 years ago for the log-normal dose-response relationship."( Fish tolerance to organophosphate-induced oxidative stress is dependent on the glutathione metabolism and enhanced by N-acetylcysteine.
Ferrando, MD; Peña, JB; Peña-Llopis, S, 2003
)
0.32
" Acute pancreatitis occurred 24 to 72 hours after dosing and was characterized by painless abdominal paralytic ileus and vomiting."( Acute pancreatitis subsequent to voluntary methomyl and dichlorvos intoxication.
Abidi, N; Amamou, M; Blel, Y; Brahmi, N; Kouraichi, N; Thabet, H, 2005
)
0.57
"After determining appropriate dosing for comparison, rodents were randomized to receive one of four intraperitoneal antidotes (n = 10 per group): 1) normal saline (0."( Pretreating rats with parenteral ophthalmic antimuscarinic agents decreases mortality from lethal organophosphate poisoning.
Aks, SE; Bryant, SM; Rhee, JW; Thompson, TM, 2007
)
0.34
"5% and 100% and increased with an increase in dosage of the insecticide."( Tolerance of house fly, Musca domestica L. (Diptera: Muscidae) to dichlorvos (76% EC) an insecticide used for fly control in the tsunami-hit coastal villages of southern India.
Boopathidoss, PS; Gunasekaran, K; Jambulingam, P; Srinivasan, R, 2008
)
0.58
" Two out of six chicks died within two hours after treatment with LD50 doses of chlorpyrifos and dichlorvos, whereas LD50 dosing with diazinon caused death in three out of six chicks."( Acute toxicity and cholinesterase inhibition in chicks dosed orally with organophosphate insecticides.
Al-Badrany, YM; Al-Jobory, MM; Mohammad, FK, 2008
)
0.56
" The dose-response curves (DRCs) between the observed inhibition toxicities and the doses of the pesticides or the mixtures were modeled by using the nonlinear least square fitting."( Combined photobacterium toxicity of herbicide mixtures containing one insecticide.
Liu, HL; Liu, SS; Song, XQ; Zhang, J; Zhang, YH, 2009
)
0.35
" In order to evaluate potential adverse health effects of low-level exposure to agrochemicals, the reproductive toxicity of the pesticides dicofol, dichlorvos, permethrin, endosulfan, and dieldrin was evaluated in rats dosed with these chemicals individually or as mixtures."( Decreased sperm motility in rats orally exposed to single or mixed pesticides.
da Silva Franchi, CA; de Camargo, JL; Fernandez, CD; Kempinas, Wde G; Martinez, MF; Perobelli, JE, 2010
)
0.56
" The objective of this study was to examine and compare the acute toxicity and cholinesterase inhibition in seven to 14-day-old chicks dosed orally with dichlorvos and diazinon in standard veterinary and agricultural formulations."( Acute toxicity of veterinary and agricultural formulations of organophosphates dichlorvos and diazinon in chicks.
Al-Zubaidy, MH; Hasan, MM; Mohammad, FK; Mousa, YJ, 2011
)
0.8
" LysoPE (16:0/0:0) was increased after dosing with DDVP."( Metabolomic analysis of rat plasma following chronic low-dose exposure to dichlorvos.
Du, L; Hao, D; Sun, C; Wang, H; Xu, W; Yang, J; Zhao, X, 2013
)
0.62
" In this study, the dose-response of cyanobacteria Microcystis wesenbergii on OPs exposure and the stimulating effect of OPs with and without phosphorus source were investigated."( Ecotoxicity of two organophosphate pesticides chlorpyrifos and dichlorvos on non-targeting cyanobacteria Microcystis wesenbergii.
Cheng, H; Duan, SS; Hong, YG; Sun, KF; Wang, YS; Xu, XR; Zhang, ZW; Zhou, GJ, 2015
)
0.66
" Field investigation of the dissipation rate kinetics for triadimefon and malathion during storage indicated that their half-life was twice as high when 5 times the recommended dosage was used."( Behavior of field-applied triadimefon, malathion, dichlorvos, and their main metabolites during barley storage and beer processing.
Bao, Y; Chen, J; Dai, X; Fan, B; Francis, F; Gui, Y; Jian, Q; Kong, Z; Li, M, 2016
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Items)

ItemProcessFrequency
Sanitizercore-ingredient1

Roles (5)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
anthelminthic drugSubstance intended to kill parasitic worms (helminths).
EC 3.1.1.8 (cholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8).
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
alkenyl phosphate
dialkyl phosphate
organophosphate insecticide
organochlorine acaricideAny organochlorine pesticide that has been used as an acaricide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
versicolorin B biosynthesis415

Protein Targets (52)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.35480.003245.467312,589.2998AID2517
interleukin 8Homo sapiens (human)Potency43.97800.047349.480674.9780AID651758
acetylcholinesteraseHomo sapiens (human)Potency23.12810.002541.796015,848.9004AID1347395; AID1347398
15-lipoxygenase, partialHomo sapiens (human)Potency39.81070.012610.691788.5700AID887
pregnane X receptorRattus norvegicus (Norway rat)Potency28.18380.025127.9203501.1870AID651751
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency4.25273.189029.884159.4836AID1224846
TDP1 proteinHomo sapiens (human)Potency20.87050.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency23.68410.000221.22318,912.5098AID588516; AID743035; AID743036; AID743053; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.66840.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency2.83710.001318.074339.8107AID926; AID938
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency22.35030.001022.650876.6163AID1224838; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency19.88170.000214.376460.0339AID588533; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency40.72040.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency6.35150.000817.505159.3239AID588544; AID588546
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency15.51160.001530.607315,848.9004AID1224841
farnesoid X nuclear receptorHomo sapiens (human)Potency16.86760.375827.485161.6524AID588526; AID588527; AID743239
pregnane X nuclear receptorHomo sapiens (human)Potency44.96470.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.49350.000229.305416,493.5996AID743069; AID743075; AID743078; AID743080; AID743091
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency20.21320.001019.414170.9645AID588536; AID588537; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency22.53580.023723.228263.5986AID588541; AID588543
activating transcription factor 6Homo sapiens (human)Potency2.73530.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency9.831219.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.57190.010039.53711,122.0200AID588545; AID588547
heat shock protein beta-1Homo sapiens (human)Potency7.66690.042027.378961.6448AID743210
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency7.19124.466824.832944.6684AID651749
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.90290.000627.21521,122.0200AID651741; AID743202; AID743219
gemininHomo sapiens (human)Potency12.61080.004611.374133.4983AID624296; AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency18.07590.005612.367736.1254AID624032; AID624044
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency15.84890.031610.279239.8107AID884; AID885
lamin isoform A-delta10Homo sapiens (human)Potency1.58490.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Cellular tumor antigen p53Homo sapiens (human)Potency10.28980.002319.595674.0614AID651631; AID651743
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Nuclear receptor ROR-gammaHomo sapiens (human)Potency47.30790.026622.448266.8242AID651802
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency26.60320.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency26.60320.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)1.46850.00000.933210.0000AID1251506; AID1251507
AcetylcholinesteraseAnopheles gambiae (African malaria mosquito)IC50 (µMol)0.19210.04360.38210.9600AID1251508; AID1251510
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (165)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (53)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (35)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (55)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID287365Insecticidal activity against Nilaparvata lugens at 500 mg/L2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Discovery of a new insecticide lead by optimizing a target-diverse scaffold: tetrazolinone derivatives.
AID1251521Insecticidal activity against Anopheles gambiae G3 assessed as fumigation mortality at 10 ng/mL after 24 hrs by mason jar assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251517Drug degradation assessed as evaporative weight loss after 6 days2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251523Insecticidal activity against Anopheles gambiae G3 assessed as mortality at 50 ng/insect after 24 hrs (Rvb = 11 +/- 4%)2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1101931Insecticidal activity against Musca domestica (house fly) after 24 hr2002Journal of agricultural and food chemistry, Sep-25, Volume: 50, Issue:20
QSAR evaluation of cyanohydrins' fumigation toxicity to house fly (Musca domestica) and lesser grain borer (Rhyzopertha dominica).
AID1251508Inhibition of recombinant Anopheles gambiae wild type AChE after 60 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251516Drug degradation assessed as evaporative weight loss after 1 day2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251518Drug degradation assessed as evaporative weight loss after 12 days2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251510Inhibition of recombinant Anopheles gambiae wild type AChE after 10 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251519Drug degradation assessed as evaporative weight loss after 28 days2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1082321Biotype susceptibility ratio, ratio of LC50 for female adult Bemisia tabaci biotype Q (sweet potato whitefly) to LC50 for female adult Bemisia tabaci biotype B2011Journal of agricultural and food chemistry, Aug-10, Volume: 59, Issue:15
Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci.
AID287366Insecticidal activity against Mythimna separata at 500 mg/L2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Discovery of a new insecticide lead by optimizing a target-diverse scaffold: tetrazolinone derivatives.
AID1251512Ratio of IC50 for recombinant Anopheles gambiae AChE G119S mutant to IC50 for recombinant wild type Anopheles gambiae AChE2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251506Inhibition of recombinant human AChE after 10 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251509Inhibition of recombinant Anopheles gambiae AChE G119S mutant after 60 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1082322Adulticidal activity against female Bemisia tabaci biotype Q (sweet potato whitefly) in cucumber leaves assessed as residual contact toxicity treated for 30 secs before adult insect infestation measured after 24 hr by leaf dip bioassay2011Journal of agricultural and food chemistry, Aug-10, Volume: 59, Issue:15
Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci.
AID1101932Insecticidal activity against Rhyzopertha dominica after 24 hr2002Journal of agricultural and food chemistry, Sep-25, Volume: 50, Issue:20
QSAR evaluation of cyanohydrins' fumigation toxicity to house fly (Musca domestica) and lesser grain borer (Rhyzopertha dominica).
AID1251511Inhibition of Anopheles gambiae AChE G119S mutant after 10 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1251507Inhibition of recombinant human AChE after 60 mins by Ellman assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
AID1082320Adulticidal activity against female Bemisia tabaci biotype B (sweet potato whitefly) in cucumber leaves assessed as residual contact toxicity treated for 30 secs before adult insect infestation measured after 24 hr by leaf dip bioassay2011Journal of agricultural and food chemistry, Aug-10, Volume: 59, Issue:15
Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,149)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990503 (43.78)18.7374
1990's127 (11.05)18.2507
2000's210 (18.28)29.6817
2010's244 (21.24)24.3611
2020's65 (5.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.98 (24.57)
Research Supply Index7.14 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index117.57 (26.88)
Search Engine Supply Index3.04 (0.95)

This Compound (46.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (0.32%)5.53%
Reviews35 (2.79%)6.00%
Case Studies52 (4.14%)4.05%
Observational0 (0.00%)0.25%
Other1,165 (92.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]